Prosper Junior Bakiny
TMFPBakiny
Prosper Junior Bakiny is a contributing Motley Fool healthcare analyst covering biotechnology, pharmaceuticals, and healthcare stocks. Before The Motley Fool, Prosper wrote about investing topics ranging from stock market news to private equity for various companies. He holds a master’s degree in corporate finance from the University of Maryland Global Campus.
Recent Articles by Prosper Junior Bakiny

Jul 24, 2025
by Prosper Junior Bakiny
The 3 Things That Matter for Eli Lilly Now

Jul 24, 2025
by Prosper Junior Bakiny
The 3 Things That Matter for AbbVie Now

Jul 20, 2025
by Prosper Junior Bakiny
Does This Move Make Merck Stock a Buy?
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.